Stryker Corporation has a robust track record of double-digit earnings growth and high single-digit organic revenue growth.

Johnson & Johnson’s medtech acquisitions over the past year have fueled growth for its cardiovascular group, offsetting ...

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating ...

Abbott Laboratories (NYSE:ABT) increased its full-year earnings guidance on Tuesday after its financials for Q3 2024 exceeded ...

Medtech Innovator announced that it awarded the grand prize for its early-stage accelerator to AI-driven tech developer Samay ...

When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...

We recently published a list of 8 High Growth UK Stocks to Invest In. In this article, we are going to take a look at where ...

JNJ's 3Q earnings expected to be $2.21 EPS and $22.16B revenue. Recent acquisitions and drug trials impacting stock's ...

Employees at the 10 largest medtech employers in the world are excited about culture but are still frustrated by corporate ...

Definitive Healthcare (Nasdaq: DH), a leader in healthcare commercial intelligence, today announced the launch of Monocl Conferences. This solution is designed to enhance conference planning and ...

Nodenza Venture Partners launchedFocus on international early-stage and pre-commercial biotech & medtech opportunitiesNew York, October 16, ...

The Impact of the Top 3 Strategic Imperatives on R&D Investment in the Medtech Industry About is the world's leading source for international market research reports and market data. We provide you ...